Leuraud Klervi, Richardson David B, Cardis Elisabeth, Daniels Robert D, Gillies Michael, O'Hagan Jacqueline A, Hamra Ghassan B, Haylock Richard, Laurier Dominique, Moissonnier Monika, Schubauer-Berigan Mary K, Thierry-Chef Isabelle, Kesminiene Ausrele
Lancet Haematol. 2015 Jul;2(7):e276-81. doi: 10.1016/S2352-3026(15)00094-0.
There is much uncertainty about the risks of leukaemia and lymphoma after repeated or protracted low-dose radiation exposure typical of occupational, environmental, and diagnostic medical settings. We quantified associations between protracted low-dose radiation exposures and leukaemia, lymphoma, and multiple myeloma mortality among radiation-monitored adults employed in France, the UK, and the USA.
We assembled a cohort of 308,297 radiation-monitored workers employed for at least 1 year by the Atomic Energy Commission, AREVA Nuclear Cycle, or the National Electricity Company in France, the Departments of Energy and Defence in the USA, and nuclear industry employers included in the National Registry for Radiation Workers in the UK. The cohort was followed up for a total of 8.22 million person-years. We ascertained deaths caused by leukaemia, lymphoma, and multiple myeloma. We used Poisson regression to quantify associations between estimated red bone marrow absorbed dose and leukaemia and lymphoma mortality.
Doses were accrued at very low rates (mean 1.1 mGy per year, SD 2.6). The excess relative risk of leukaemia mortality (excluding chronic lymphocytic leukaemia) was 2.96 per Gy (90% CI 1.17-5.21; lagged 2 years), most notably because of an association between radiation dose and mortality from chronic myeloid leukaemia (excess relative risk per Gy 10.45, 90% CI 4.48-19.65).
This study provides strong evidence of positive associations between protracted low-dose radiation exposure and leukaemia.
Centers for Disease Control and Prevention, Ministry of Health, Labour and Welfare of Japan, Institut de Radioprotection et de Sûreté Nucléaire, AREVA, Electricité de France, National Institute for Occupational Safety and Health, US Department of Energy, US Department of Health and Human Services, University of North Carolina, Public Health England.
在职业、环境及诊断性医疗环境中典型的反复或长期低剂量辐射暴露之后,白血病和淋巴瘤的风险存在诸多不确定性。我们对法国、英国和美国接受辐射监测的成年工作人员中,长期低剂量辐射暴露与白血病、淋巴瘤及多发性骨髓瘤死亡率之间的关联进行了量化。
我们组建了一个队列,其中包括308297名接受辐射监测的工作人员,他们在法国受原子能委员会、阿海珐核循环公司或国家电力公司雇佣至少1年,在美国受能源部和国防部雇佣,在英国受国家辐射工作人员登记处纳入的核工业雇主雇佣。该队列总共随访了822万人年。我们确定了由白血病、淋巴瘤和多发性骨髓瘤导致的死亡。我们使用泊松回归来量化估计的红骨髓吸收剂量与白血病和淋巴瘤死亡率之间的关联。
剂量累积速率非常低(平均每年1.1毫戈瑞,标准差2.6)。白血病死亡率(不包括慢性淋巴细胞白血病)的超额相对风险为每戈瑞2.96(90%置信区间1.17 - 5.21;滞后2年),最显著的是由于辐射剂量与慢性髓细胞白血病死亡率之间的关联(每戈瑞超额相对风险10.45,90%置信区间4.48 - 19.65)。
本研究提供了长期低剂量辐射暴露与白血病之间存在正相关的有力证据。
疾病控制与预防中心、日本厚生劳动省、法国辐射防护与核安全研究所、阿海珐集团、法国电力公司、美国国家职业安全与健康研究所、美国能源部、美国卫生与公众服务部、北卡罗来纳大学、英国公共卫生部。